"
Triple Effect of Doxorubicin, 5-Fluorouracil, Propranolol on Cell Survival on MCF-7 Breast Cancer Cell Line"
written by Onur Eroglu, Hacer Kaya, Esin Guvenir Celik, Merve Celen, Elif Korkut, Nagihan Nizam,
published by
Journal of Biosciences and Medicines,
Vol.7 No.2, 2019
has been cited by the following article(s):
|
[1]
|
Combined treatment with ruxolitinib and MK-2206 inhibits the JAK2/STAT5 and PI3K/AKT pathways via apoptosis in MDA-MB-231 breast cancer cell line
Molecular Biology Reports,
2023
DOI:10.1007/s11033-022-08034-4
|
|
|
|
|
[2]
|
Combined treatment with ruxolitinib and MK-2206 inhibits the JAK2/STAT5 and PI3K/AKT pathways via apoptosis in MDA-MB-231 breast cancer cell line
Molecular Biology Reports,
2022
DOI:10.1007/s11033-022-08034-4
|
|
|
|
|
[3]
|
Akrep Hemolenfinin Kanser Hücrelerinde Antiproliferatif ve Morfolojik Etkilerinin Araştırılması
Bilecik Şeyh Edebali Üniversitesi Fen Bilimleri Dergisi,
2020
DOI:10.35193/bseufbd.682149
|
|
|
|
|
[4]
|
Akrep Hemolenfinin Kanser Hücrelerinde Antiproliferatif ve Morfolojik Etkilerinin Araştırılması
Bilecik Şeyh Edebali Üniversitesi Fen Bilimleri Dergisi,
2020
DOI:10.35193/bseufbd.682149
|
|
|
|